CMRA (Comera Life Sciences Holdings) Total Equity: $-4.22 Mil (As of Sep. 2023)


What is Comera Life Sciences Holdings Total Equity?

Comera Life Sciences Holdings CMRA Total Equity is $-4.22 Mil as of Sep. 2023.

Comera Life Sciences Holdings's total equity for the quarter that ended in Sep. 2023 was $-4.22 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Comera Life Sciences Holdings Total Equity Historical Data

* Premium members only.

The historical data trend for Comera Life Sciences Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Comera Life Sciences Holdings Total Equity Chart

Comera Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22
Total Equity
0.15 -14.69 -6.25

Comera Life Sciences Holdings Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -3.43 -6.25 -5.27 -6.35 -4.22

Comera Life Sciences Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Comera Life Sciences Holdings's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity=Total Assets(Q: Dec. 2022 )-Total Liabilities(Q: Dec. 2022 )
=3.727-9.974
=-6.25

Comera Life Sciences Holdings's Total Equity for the quarter that ended in Sep. 2023 is calculated as

Total Equity=Total Assets(Q: Sep. 2023 )-Total Liabilities(Q: Sep. 2023 )
=3.072-7.293
=-4.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-4.22 Mil mean?
Comera Life Sciences Holdings (CMRA) has a Total Equity of $-4.22 Mil as of Sep. 2023. The total amount of equity as record on a company's balance sheet. View historical data for Comera Life Sciences Holdings and its competitors.
Is Comera Life Sciences Holdings' Total Equity too high?
Comera Life Sciences Holdings' current Total Equity is $-4.22 Mil.
How does Comera Life Sciences Holdings' Total Equity compare to FREQ and BNTC?
Comera Life Sciences Holdings' Total Equity of $-4.22 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Comera Life Sciences Holdings and its competitors. Comera Life Sciences Holdings's current Total Equity is $-4.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Comera Life Sciences Holdings stock overvalued right now?
Comera Life Sciences Holdings (CMRA) has a current Total Equity of $-4.22 Mil. The current Total Equity is $-4.22 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Comera Life Sciences Holdings (CMRA), the current Total Equity is $-4.22 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Comera Life Sciences Holdings Business Description

Address 12 Gill Street, Suite 4650, Woburn, MA, USA, 01801
Comera Life Sciences Holdings Inc is a pre-clinical biotechnology company dedicated to promoting formulation science and technology to transform essential biologic medicines from intravenous to subcutaneous forms. Comera's internal portfolio of proprietary techniques known as the SQore platform is designed to potentially transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, and optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. It also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to the Company's partners' biologic medicines to deliver enhanced formulations that facilitate self-injectable care.